期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

老年冠状动脉粥样硬化性心脏病抗血小板药物治疗的临床评价 被引量：4

Antiplatelet Therapy for Coronary Heart Disease in the Elderly
下载PDF
导出
摘要 冠状动脉粥样硬化性心脏病患者以老年人居多,循证医学研究显示,冠状动脉粥样硬化性心脏病患者强化抗血小板治疗,心脏事件发生率会明显降低。现就老年冠状动脉粥样硬化性心脏病抗血小板治疗的临床现状做一综述。 Elderly patients suffer the highest rate of coronary heart disease.Evidence-based medicine shows that antiplatelet therapy significantly reduces vascular mortality.This article reviews the use of antiplatelet therapy for coronary heart disease in the elderly.
作者 张亚梅 陈庆伟
机构地区 重庆医科大学附属第二医院老年病科
出处 《心血管病学进展》 CAS 2011年第2期220-224,共5页 Advances in Cardiovascular Diseases
关键词 冠状动脉粥样硬化性心脏病 老年人 阿司匹林 氯吡格雷 血小板膜糖蛋白Ⅱb/Ⅲa受体拮抗剂 coronary heart disease elderly aspirin clopidogrel glycoprotein Ⅱb/Ⅲa inhibitors
分类号 R541.4 [医药卫生—心血管疾病] R973 [医药卫生—药品]
  • 相关文献

参考文献2

二级参考文献7

  • 1Jeffrey S. Berger,Maria C. Roncaglioni,Fausto Avanzini,Ierta Pangrazzi,Gianni Tognoni,David L. Brown,崔艳丽（译）,赵秀丽（校）.阿斯匹林在男性和女性心血管事件一级预防中的应用——随机对照试验性别特异性汇总分析[J].美国医学会杂志（中文版）,2006,25(5):275-282. 被引量：40
  • 2Crouch M A,Nappi J M,Cheang K I.Glycoprotein Ⅱb/ Ⅲa receptor inhibitors in percutaneous coronary interven- tion and acute coronary syndrome[].Annals of Pharmacotherapy.2003
  • 3Boersma E,Harrington R A,Moliterno D J et al.Platelet glycoprotein Ⅱb/Ⅲa inhibitors in acute coronary syn- dromes: a meta-analysis of all major randomised clinical trials[].The Lancet.2002
  • 4The PRISM-PLUS Study Investigators.Inhibition of the platelet glycoprotein Ⅱb/Ⅲa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction[].The New England Journal of Medicine.1998
  • 5Kim J H,Jeong M H,Rhew J Y et al.Long-term clinical outcomes of platelet glycoprotein Ⅱb/Ⅲa inhibitor com- bined with low molecular weight heparin in patients with acute coronary syndrome[].Circulation Journal.2005
  • 6Tcheng J E,Ellis S E,George B S et al.Pharmacody- nam-ics of chimeric glycoprotein Ⅱb/Ⅲa integrin anti- platelet anti-body Fab 7E3 in high-risk coronary angio- plasty[].Circulation.1994
  • 7Stone G W,Moliterno D J,Bertrand M et al.Impact of clinical syndrome acuity on the differential response to 2 glycoprotein Ⅱb/Ⅲa inhibitors in patients undergoing coronary stenting: The TARGET Trial[].Circulation.2002

共引文献33

同被引文献45

  • 1柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量：2125
  • 2Hennekens CH. Aspirin in the treatment and prevention of cardiovascular disease: current perspective and future directions. Curr Atheroscler Rep, 2007,9 : 409-416.
  • 3Serebruany VL, Atar D. Assessment of bleeding events in clinical trials-proposal of a new classification. Am J Cardiol, 2007,99: 288-290.
  • 4Zullo A, Hassan C, Campo SM, et al. Bleeding peptic ulcer in the elderly: risk factors and prevention strategies. Drugs Aging, 2007,24:815-828.
  • 5Pilotto A, Franceschi M, Maggi S, et al. Optimal management of peptic ulcer disease in the elderly. Drugs Aging, 2010,27: 545-558.
  • 6Garcia-Rodriguez LA,Barreales-Tolosa L. Risk of upper gas trointestinal complications among users of traditional NSAIDs and COXIBs in the general population. Gastroenterologym, 2007,132:498-506.
  • 7Rostom A,Muir K,Dube C, et al. Gastrointestinal safety of cyelooxygenase-2 inbibitors:a coehrane collaboration system atie review. Clin Gastroenterol Hepatol, 2007,5 : 818-828.
  • 8Malfertheiner P, Megraud F, O' Morain C, et al. Current con cepts in the management of helicobacter pylori infection: the Maastrieht Ⅲ Consensus Report. Gut, 2007,56 : 772-781.
  • 9Hennekens CH. Aspirin in the treatment and prevention of cardiovas- cular disease:current perspective and future directions [ J ]. Curt Ather Oscler Rep ,2007,9(5 ) :409-416.
  • 10Zullo A, Hassan C, Campo SM, et al. Bleeding peptic ulcer in the eld- erly:risk factors and prevention strategies [ J ]. Drugs Aging, 2007, 24 (10) :815-828.

引证文献4

二级引证文献82

心血管病学进展
2011年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部